BriaCell Therapeutics Dividend
Dividend criteria checks 0/6
BriaCell Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 1.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$0.20 |
| Dividend yield forecast | n/a |
Recent dividend updates
No updates
Recent updates
BriaCell stock rises on license deal for anti-cancer agent
Aug 04BriaCell partners with Waisman Biomanufacturing to make & supply prostate cancer therapy
Jul 05BriaCell, Harvard enter research agreement to identify targets for cancer treatments
Jun 29BriaCell Therapeutics receives proceed of $12.88M from warrant exercises
Jun 10BriaCell Therapeutics skyrockets 104% on robust overall survival benefit in advanced breast cancer patients
Jun 02Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BCTX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BCTX's dividend payments have been increasing.
Dividend Yield vs Market
| BriaCell Therapeutics Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BCTX) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Biotechs) | 1.9% |
| Analyst forecast (BCTX) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate BCTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BCTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BCTX's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BCTX has not reported any payouts.